OptimizeRx CorporationOPRXNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR+21.3%
5Y CAGR-21.6%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
+21.3%/yr
vs -45.4%/yr prior
5Y CAGR
-21.6%/yr
Recent acceleration
Acceleration
+66.7pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202516.66%
202438.41%
202310.09%
20229.34%
202147.84%
202056.13%
201926.48%
2018105.06%
201737.16%
201620.61%